ANTXR2 and soft tissue sarcoma: CMG2 protein expression was not significantly associated with soft tissue sarcoma patient survival (p = 0.07; log-rank test; see Figure 3c); however, the patient group with a low CMG2 protein expression also exhibited a decreased median survival time of 20 months in comparison to 86 months for patients with a high CMG2 protein expression.